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Abstract. 
 
Previous reports have indicated that DNA-
damaging treatments including certain anticancer ther-
apeutics cause death of postmitotic nerve cells both in 
 
vitro
 
 
 
and
 
 
 
in vivo. Accordingly, it has become important 
to understand the signaling events that control this pro-
cess. We recently hypothesized that certain cell cycle 
molecules may play an important role in neuronal 
death signaling evoked by DNA damage. Conse-
quently, we examined whether cyclin-dependent kinase 
inhibitors (CKIs) and dominant-negative (DN) cyclin-
dependent kinases (CDK) protect sympathetic and cor-
tical neurons against DNA-damaging conditions. We 
show that Sindbis virus–induced expression of CKIs 
 
p16
 
ink4
 
, p21
 
waf/cip1
 
, and p27
 
kip1
 
, as well as DN-Cdk4 and 
6, but not DN-Cdk2 or 3, protect sympathetic neurons 
against UV irradiation– and AraC-induced death. We 
also demonstrate that the CKIs p16 and p27 as well as 
DN-Cdk4 and 6 but not DN-Cdk2 or 3 protect cortical 
neurons from the DNA damaging agent camptothecin. 
 
Finally, in consonance with our hypothesis and
 
 
 
these 
results, cyclin D1–associated kinase activity is rapidly 
and highly elevated in cortical neurons
 
 
 
upon campto-
thecin treatment. These results suggest that postmitotic 
neurons may utilize Cdk4 and 6, signals that normally 
control proliferation, to mediate death signaling result-
ing from DNA-damaging conditions.
Key words: apoptosis • CDK • neuronal • cell cycle • 
DNA damage
 
N
 
umerous
 
 anticancer therapeutics activate death
processes by creating DNA damage in a manner
that is frequently dependent on the cell’s prolifer-
ative capacity (Gorczyca et al., 1993). Recently, however,
several reports have indicated that DNA-damaging agents
also activate death programs in terminally differentiated
postmitotic neurons (Winkelman and Hines, 1983; Wal-
lace and Johnson, 1989; Martin et al., 1990; Morris and
Geller, 1996; Park et al., 1997
 
a
 
, 1998; Gill and Windebank,
1998). Examples include irradiation (Enokido et al., 1996),
the S phase inhibitor cytosine arabinoside (AraC)
 
1
 
 (Win-
kelman and Hines, 1983; Wallace and Johnson, 1989; Mar-
tin et al., 1990; Tomkins et al., 1994; Park et al., 1998), the
DNA topoisomerase-II inhibitors etoposide, teniposide,
and mitoxanthrone (Nakajima et al., 1994; Tomkins et al.,
1994), cisplatin (Gill and Windebank, 1998), and camp-
tothecin, a topoisomerase-I inhibitor (Morris and Geller,
1996; Park et al., 1997
 
a
 
). Interestingly, several of these
agents cause peripheral neuropathies and neurodegenera-
tion (Winkelman and Hines, 1983; Baker et al., 1991; Vo-
gel and Horoupian, 1993; Mansfield and Castillo, 1994).
Accordingly, it is important to understand how these
agents cause neuronal death. Recent evidence suggests
that cell death by these agents is subsequent to formation
of DNA strand breaks (Morris and Geller 1996; Morris,
E.J., D.S. Park, J.C. Dreixler, L.A. Greene, and H.M.
Greene. 1997. 
 
Soc. Neurosci. Abstr.
 
 23:881). However, the
downstream events that occur after treatment with such
genotoxic agents remain unclear.
Cell cycle components may play a role in apoptotic sig-
naling of proliferating cells induced to die by DNA dam-
age. For example, increased cdc2 (Shimizu et al., 1995)
and cyclin E–associated (Ping Dou et al., 1995) kinase ac-
tivities in response to DNA-damaging agents have been
demonstrated. Other evidence suggests that cell cycle
components also play a role in certain cases of apoptotic
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death of postmitotic neurons. For instance, neuronal apop-
tosis caused by loss of trophic support is accompanied by
changes in cyclin-dependent kinase (CDK) activity and cy-
clin expression (Brooks, S.F., L.A. Gibson, and L.L. Ru-
bin. 1993. 
 
Soc. Neurosci. Abstr.
 
 19:885; Freeman et al.,
1994; Gao and Zalenka, 1995) and agents that inhibit cell
cycle progression, including G1/S blockers (but not S and
M phase blockers) (Farinelli and Greene, 1996), as well as
the CDK inhibitors, flavopiridol and olomoucine (Park et al.,
1996
 
a
 
), promote survival of neuronal PC12 cells and sym-
pathetic neurons deprived of serum and/or NGF. More-
over, expression of the CDK inhibitors p16, p21, and p27
as well as of dominant-negative (DN) forms of CDK4 and
6 inhibits death of sympathetic neurons caused by NGF
withdrawal (Park et al., 1997
 
b
 
).
Because cell cycle components appear to play a role in
death of proliferating cells induced by DNA damage as
well as in death of NGF-deprived postmitotic neurons, we
hypothesized that neuronal death resulting from DNA-
damaging agents may also use components that normally
control cell cycle progression in proliferating cells (Park
et al., 1997
 
a
 
, 1998). In support of this model, we have pre-
viously shown that pharmacological G1/S blockers and
CDK inhibitors inhibit death of neuronal PC12 cells and
sympathetic neurons exposed to DNA-damaging agents
including UV irradiation, camptothecin, and AraC (Park
et al., 1997
 
a
 
, 1998).
The present study had two major aims. The first was
to confirm the potential role that our pharmacologically
based studies have suggested for cell cycle–associated mol-
ecules, and in particular, cyclin-dependent kinases, in neu-
ronal apoptosis evoked by DNA damage. The second was
to identify at least several of the molecules in question. To
achieve these ends, we used the Sindbis virus to target spe-
cific cell cycle regulatory genes to cultured rat sympathetic
and cortical neurons. Sindbis virus, a positive-sense RNA
alphavirus is neuronotropic and replication competent
and, by use of a double subgenomic Sindbis promoter, per-
mits expression of heterologous genes (Xiong et al., 1989;
Levine et al., 1991, 1993, 1996; Hahn et al., 1992; Piper et al.,
1992; Schlesinger, 1993; Cheng et al., 1996; Joe et al.,
1996). It was previously shown that Sindbis virus effi-
ciently targets heterologous genes to cultured sympathetic
neurons and is an effective tool to study the role of cell cy-
cle genes in death of sympathetic neurons induced by
NGF deprivation (Park et al., 1997
 
b
 
).
Because previous pharmacologic evidence suggested
that CDK activity is required for neuronal death resulting
from DNA damage (Park et al., 1997
 
a
 
, 1998), we focused
our studies in this direction. The CDK family, which in-
cludes Cdk2, Cdk3, Cdk4/6, and Cdc2 among others, is an
important group of molecules that regulate cell prolifera-
tion (Pines, 1993). In addition, two classes of mammalian
cyclin-dependent kinase inhibitors (CKIs) have been de-
scribed (for review see Sherr and Roberts, 1995). Cip/kip
members, which include p21, p27, and p57, inhibit the ac-
tivities of a wide range of CDK–cyclin complexes. In com-
parison, ink4 family members, including p15, p16, p18, and
p19, appear to primarily inhibit the activity of Cdk4/6–
cyclin D complexes. In the present studies we examined
the role of CDKs in death of neurons caused by DNA
damaging agents. To do so, we used Sindbis virus–medi-
 
ated expression of CKIs as well as of DN forms of individ-
ual G1 CDKs and evaluated cyclin D1–associated kinase
activity.
 
Materials and Methods
 
Generation of Recombinant Sindbis
 
The coding regions of p16 (Serrano et al., 1993), p21 (Harper et al., 1993),
and p27 (Polyak et al., 1994) were subcloned into the BSTEII site of the
DSTEQ12 Sindbis virus vector (Joe et al., 1996) downstream of a double
subgenomic Sindbis viral promoter. The coding regions of DN cdk2, 3, 4,
and 6 (van den Heuvel and Harlow, 1993) and the single chain ScFv con-
trol (R6) cDNA was inserted into the XbaI site of the DSTEQ12 vector.
The putative DN forms of the CDKs have been previously reported as in-
activating Asp to Asn point mutations in the kinase domain (van den
Heuvel and Harlow, 1993). The CAT recombinant viruses were generated
previously (Cheng et al., 1996; Levine et al., 1996). FLAG tags
(ATGGACTACAAGGACGATGATGACAAA) were introduced at
the 3
 
9
 
 end of the coding region of p27, p16, DN Cdk2, DN Cdk3, DN
Cdk4, and DN Cdk6. Control non-expressing vectors of the CDK inhibi-
tors were generated by eliminating the initiating codon of each inhibitor
and in the case of p16, p21, Cdk3, Cdk4, and Cdk6, introducing a prema-
ture stop codon shortly after the second methionine in each coding region
(Park et al., 1997
 
b
 
). All mutations, deletions, and FLAG tags were intro-
duced by PCR and confirmed by sequencing. Viral particles were gener-
ated by in vitro translation and transfection into BHK cells and titered by
plaque assay as previously described (Joe et al., 1996).
 
Culture and Survival Assay of Rat
Sympathetic Neurons
 
Primary cultures of rat sympathetic neurons were obtained from dissoci-
ated superior cervical ganglia of postnatal day 1 rats (strain; Harlan Sprague
Dawley Inc., Indianapolis, IN) as described previously (Park et al., 1996
 
b
 
).
The cells were plated in 0.5 ml of medium per well in collagen-coated 24-
well dishes at a density of 
 
z
 
0.5 ganglia/well (
 
z
 
10,000 neurons/well). The
growth medium was RPMI 1640 medium supplemented with 10% heat-
inactivated horse serum (JRH Biosciences, Lenexa, KS) and 60 ng/ml
mouse NGF (Sigma Chemical Co., St. Louis, MO). To eliminate non-neu-
ronal cells, a mixture of uridine and 5-fluorodeoxyuridine (10 
 
m
 
M each)
were added to the cultures on the following day. 3 d after plating, the neu-
rons were infected with Sindbis virus (plaque-forming units per cell of 1 to
2) in 0.2 ml of RPMI 1640 media containing 2% heat-inactivated horse se-
rum. After 1 h of infection, 0.3 ml of RPMI 1640 medium containing 16%
heat-inactivated horse serum was added. The cultures were then treated
immediately with 100 
 
m
 
M AraC or left to incubate overnight before UV
irradiation (300 J/m
 
2
 
). To achieve the latter, each well containing 200 
 
m
 
l of
medium containing NGF was exposed in a Stratolinker (Stratagene, La
Jolla, CA). After irradiation, 300 
 
m
 
l of additional medium containing
NGF with or without drug was added to each well. At appropriate times,
the numbers of viable, phase bright neurons were determined by strip
counting as previously described (Rydel and Greene, 1988).
 
Culture and Survival of Cortical Neurons
 
Rat cortical neurons were cultured from embryonic day 18 rats as previ-
ously described (Friedman et al., 1993). The neurons were plated into 24-
well dishes (
 
z
 
200,000 cells/well) coated with polylysine in serum-free me-
dium (N2/MEM [1:1] supplemented with 6 mg/ml 
 
d
 
-glucose, 100 
 
m
 
g/ml
transferrin, 25 
 
m
 
g/ml insulin, 20 nM progesterone, 60 
 
m
 
M putrescine, 30 nM
selenium). 1 d after plating, the neurons were infected with virus at a mul-
tiplicity of infection of 
 
z
 
0.5 and incubated overnight. The medium was
then exchanged with serum-free medium supplemented with 10 
 
m
 
M
camptothecin where appropriate. At appropriate times of culture under
the conditions described in the text, cells were lysed and the numbers of
viable cells were evaluated as previously described (Rukenstein et al.,
1991). All experimental points are expressed as a percentage of cells plated
on day 0 and are reported as mean 
 
6 
 
SEM (
 
n
 
 5 
 
3).
 
Immunofluorescence
 
 
 
Sympathetic neurons or cortical neurons were dissociated and cultured, as
described above, in 6-well plates at a density of 2 ganglion/well (sympa- 
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thetic neurons) or 200,000 cells/well (cortical neurons). After various
times of infection, neurons were fixed with 100% ethanol for 20 min at
 
2
 
20
 
8
 
C, blocked with PBS containing 2% horse serum, and incubated with
anti-FLAG primary antibody (cat No. IBI3010 [1:20 dilution]; Fisher Sci-
entific Co., Pittsburgh, PA) and FITC-conjugated horse anti–mouse sec-
ondary antibody (1:50 dilution; Vector Labs, Inc., Burlingame, CA).
 
Western Blot Analyses 
 
Cortical neurons were dissociated and cultured as described above. 24 h
after infection, the neurons were harvested in Laemmli buffer and 50 
 
m
 
g
of protein were loaded onto SDS–polyacrylamide gels, and then trans-
ferred onto nitrocellulose membrane as previously described (Cunning-
ham et al., 1997). Blots were probed with anti-FLAG antibody (10 
 
m
 
g/ml).
 
Cyclin D1–associated Kinase Assay 
 
D1-associated kinase activity was performed as previously described
(Matsushime et al., 1994). In brief, cortical neurons were treated for vari-
ous times with camptothecin (10 
 
m
 
M). The cells were washed twice with
cold PBS and harvested in IP buffer as previously described (Matsushime
et al., 1994). Cell lysates were then precleared by incubation with 75 
 
m
 
l
protein G–agarose beads (Sigma Chemical Co.) for 1 h. 1 
 
m
 
g of anticyclin
D1 antibody (Santa Cruz Biotechnology, Santa Cruz, CA) was then added
to 300 
 
m
 
g of cell lysate and incubated for 3 h. As control, lysate containing
no antibody was used. 50 
 
m
 
l of protein G beads were then added to the ly-
sates and incubated for 1 h. Washing and kinase assay was performed as
previously described (Matsushime et al., 1994). pRb (1 
 
m
 
g; Santa Cruz
Biotechnology) was used as substrate. pRb was then resolved on a 10%
SDS–polyacrylamide gel and incorporation of P
 
32
 
 was analyzed by autora-
diography and densitometry.
 
Results
 
CKI Expression Protects Sympathetic Neurons from 
Death Evoked by UV Irradiation and AraC Treatment
 
To test the hypothesis that CDK activity is a required ele-
ment for neuronal apoptosis evoked by DNA-damaging
agents, we used Sindbis virus to express CKIs and kinase
inactive mutant forms of G1-associated CDKs in sympa-
thetic neurons and evaluated the effects of expression on
neuronal death evoked by UV irradiation and AraC treat-
ment. We have previously shown that infection with re-
combinant Sindbis virus is an efficient means by which to
target and express heterologous genes in sympathetic neu-
rons and that the presence of the virus itself does not inter-
fere with the apoptotic pathway (Park et al., 1997
 
b
 
). We
first assessed the effects of expression of CKI genes deliv-
ered by Sindbis virus on UV-irradiated or AraC-treated
sympathetic neurons. Recombinant Sindbis viruses con-
taining the CKIs p16, p21, or p27 were engineered as pre-
viously described (Park et al., 1997
 
b
 
). The latter two were
tagged with the FLAG epitope at their COOH-terminal
ends. In a past study, these behaved comparably to non-
 
Figure 1.
 
Expression of CDK inhibitors using the Sindbis viral
delivery system suppresses death of primary cultured sympathetic
neurons irradiated with UV. Each point is the mean 
 
6 
 
SEM of
data from three cultures and is expressed relative to the number
of neurons present in each culture at the time of UV irradiation.
Control viruses for each vector were generated by removal of the
start codon and in some cases, introduction of a premature stop
site. 
 
F
 
, the wild-type protein has a FLAG epitope attached to the
COOH terminus. Effects of overexpression of (
 
a
 
)
 
 
 
p16, (
 
b
 
) p21,
(
 
c
 
) p27 and respective controls on the time course of survival of
sympathetic neurons after UV irradiation. 
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tagged constructs in providing protection from death
caused by NGF deprivation (Park et al., 1997
 
b
 
). Control
viruses for each CKI-containing Sindbis vector were con-
structed with the initiation codon deleted and a premature
stop codon introduced near the 5
 
9
 
 terminus if another me-
thionine was present within 200 bp downstream of the
Sindbis virus promoter. We have shown that epitope-
tagged p27 and p16 proteins are detected in almost all the
neurons after 2 d of infection under the conditions de-
scribed here (Park et al., 1997
 
b
 
). In addition, we have
shown that in neuronal cultures infected with CAT-expres-
sing Sindbis; CAT activity was detectable 
 
#
 
7 d after infec-
tion (Park et al., 1997
 
b
 
).
Each of the CKI-expressing Sindbis viruses, but not the
control “non-coding/stop” recombinant constructs, pro-
moted survival of infected sympathetic neurons exposed to
UV irradiation (300 J/m
 
2
 
) or AraC (100 
 
m
 
M) in the continu-
ous presence of trophic support by NGF. All three CKIs
showed comparable survival effects in each paradigm of
DNA damage. As shown in Fig. 1, 1 and 2 d after UV irradi-
ation, 
 
z
 
70–80% of the neurons expressing the CKIs were
viable as compared with only 30–40% in control irradiated
cultures. Protection with the CKIs was also observed for
AraC-induced death of sympathetic neurons. 2 d after
AraC treatment, 
 
z
 
50–55% of the neurons died in the con-
trol cultures whereas only 
 
z
 
20% death was observed for
the CKI-expressing neurons (Fig. 2). Neurons rescued by
the CKIs displayed phase bright cell bodies typical of viable
cells and intact neurites. Uninfected or control virus–infected
dying neurons displayed dark apoptotic bodies and degen-
erating neurites (Fig. 3; data not shown).
To determine whether the survival-promoting activities we
observed were not simply due to heterologous protein ex-
pression by the Sindbis virus, we infected neuronal cultures
with recombinant viruses expressing either CAT or a control
single chain antibody (ScFv). Infection with these viruses had
no effect on the rate of death of sympathetic neurons exposed
to UV irradiation or AraC treatment (data not shown).
Some degree of cytotoxicity was observed after 3 d in
cultures not exposed to DNA-damaging agents and in-
fected with p16-, p21-, or p27-expressing recombinant vi-
rus (Fig. 1; data not shown). The reasons for this are unclear.
 
Expression of
 
 
 
Kinase Inactive Cdk4 or Cdk6, but
Not Cdk2 or Cdk3, Protects Sympathetic Neurons from 
UV Irradiation and AraC Treatment
 
We next examined whether the effects of the CKIs might
be due, at least in part, to effects on CDKs, and if so, to de-
termine which CDKs may play a required role in DNA
 
Figure 2.
 
Expression of CDK inhibitors using the Sindbis viral
delivery system suppress death of primary cultured sympathetic
neurons treated with AraC. Each point is the mean 
 
6 
 
SEM of
data from three cultures and is expressed relative to the number
of neurons present in each culture at the time of AraC treatment.
Control viruses for each vector were generated by removal of the
start codon and in some cases, introduction of a premature stop
site. 
 
FLAG
 
, the wild type protein has a FLAG epitope attached
to the COOH terminus. Effects of overexpression of (
 
a
 
)
 
 
 
p16, (
 
b
 
)
p21, (
 
c
 
) p27 and respective controls on the time-course of survival
of sympathetic neurons after AraC treatment. 
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damage–induced neuronal death. Previous pharmacologic
studies suggested that neuronal death evoked by DNA-
damaging agents requires the participation of CDKs in-
volved in G1 to S progression (Park et al., 1997
 
a
 
, 1998).
Consequently, we constructed recombinant Sindbis virus–
expressing kinase inactive
 
 
 
forms of Cdk2, Cdk3, Cdk4, and
Cdk6 (all with or without FLAG tags). These point mu-
tants were first described by van den Heuvel and Harlow
(1993) and appear to act as DNs (see Discussion).
 
 
 
Cdks 2
and 3 are
 
 
 
reported to be associated with G1 progression of
actively dividing cells (van den Heuvel and Harlow, 1993);
whereas Cdks 4 and 6 appear to control entry into S phase
of cells emerging from quiesence (Doree and Galas, 1994;
Diehl and Sherr, 1997; Connell-Crowley et al., 1998). Neu-
ronal expression of each DN CDK was confirmed by im-
munofluorescent localization of the FLAG epitope. This
revealed that essentially all neurons expressed the epitope
after infection and that there was a degree of variation of
level of expression from cell to cell. Expression of the DN
CDKs was detected up to at least 7 d after infection (Fig.
4; data not shown). Sindbis virus–mediated expression of
DN
 
 
 
Cdk4 or 6 significantly delayed death of neurons ex-
posed to UV irradiation. 2–4 d after irradiation, 
 
z
 
80–90%
survival was observed for cultures infected with virus ex-
pressing DN Cdk4/6, whereas those neurons that were un-
infected or infected with control virus showed only 
 
z
 
25–
35% survival (Fig. 5, 
 
c
 
 and 
 
d
 
). In contrast, infection with
Sindbis virus–expressing DN
 
 
 
Cdk2 or Cdk3 had no effect
on survival of UV-irradiated neurons (Fig. 5, 
 
a
 
 and 
 
b
 
).
Expression of DN Cdk4 and 6 significantly delayed the
death of AraC-treated sympathetic neurons (
 
z
 
80–85%
survival at day 2 with DN Cdk4/6 versus 
 
z
 
50% survival in
cultures infected with control viruses or uninfected; Fig. 6,
 
c
 
 and 
 
d
 
). Unlike the case of UV treatment, however, sur-
vival of AraC-treated cells fell beyond 2 d in cultures ex-
pressing DN
 
 
 
Cdk4/6 expression. The reason for this is un-
clear but one possibility is that continual exposure to
AraC may overwhelm the abilities of the DN
 
 
 
CDKs to in-
hibit the presumed continual generation of apoptotic sig-
nals. Again, DN
 
 
 
Cdk2 or 3 expression had no effect on
death of AraC-treated sympathetic neurons (Fig. 6, 
 
a
 
 and
 
b
 
). The appearances of neurons rescued by DN
 
 
 
Cdk4/6 ex-
pression is similar to those rescued by the CKIs.
Expression of p16 and p27 and DN Cdk4/6
but Not DN Cdk2/3 Protects Cortical Neurons from 
Camptothecin-induced Death
Given the protection of sympathetic neurons from DNA-
Figure 3. Phase-contrast micrographs of rat sympathetic neurons
maintained in NGF-containing medium and treated for 2 d with
the following: (a) no additives, (b) UV, (c) p16-Sindbis virus 1
UV, and (d) p16 control-Sindbis virus 1 UV.
Figure 4. Immunofluorescence (a, c) staining
with an antibody directed against the FLAG
epitope or corresponding light micrographs (b, d)
of sympathetic neurons in culture infected with
Sindbis virus–expressing Cdk3DN-FLAG (c, d)
or containing the Cdk3 control “stop” sequence
(a, b). Neurons were stained seven days post-
infection.The Journal of Cell Biology, Volume 143, 1998 462
damaging agents provided by expression of CKIs and DN
Cdk4/6, we extended our observations to neurons of the
central nervous system. Cultures highly enriched in corti-
cal neurons were obtained from 18-d-old rat embryos and
death was induced by exposure to the topoisomerase in-
hibitor camptothecin (10 mM; Morris and Geller, 1996).
Within 1 d, .90% of the neurons were killed by this drug.
Past studies suggest that such death is due to transcrip-
tionally mediated DNA damage formation (Morris and
Geller, 1996; Park et al., 1997a; Morris, E.J., D.S. Park,
J.C. Dreixler, L.A. Greene, and H.M. Greene. 1997. Soc.
Neurosci. Abstr. 23:881). Experiments were carried out
with cultures infected with the variety of recombinant
Sindbis viruses described above for 1 d before treatment
and for an additional 24 h in the presence of 10 mM camp-
tothecin. Immunofluorescence studies on cultures infected
with virus-expressing FLAG-tagged DN Cdk3 and Cdk6
revealed expression in almost all neurons (Fig. 7; data not
shown). No expression of CDKs was observed in cultures
infected with “stop” control viruses. In addition, Western
blot analyses of these cultures verified that the various
FLAG-tagged DN CDKs were expressed at similar levels
(Fig. 8 a). Blotting also confirmed the expression of p16
and p27 (Fig. 8 b). For unknown reasons, the virus-con-
taining FLAG-tagged p21 failed to yield detectable levels
of expression in cortical neurons and so was not further
pursued. Control cultures exposed to the viruses and not
exposed to camptothecin showed a modest (25–35%) loss
of viability at 24 h. Also, most control viruses showed a
small, but consistent survival-promoting effect on camp-
tothecin-treated cortical neurons (10–25% survival) when
compared with uninfected (4% survival) cultures (Fig. 9).
Irrespective of these background effects, as shown in Fig.
9, p16, p27, DN Cdk4, and DN Cdk6 conferred significant
protection from camptothecin treatment. Survival in these
cases was nearly equal to that observed in virus-treated
cultures that lacked camptothecin exposure (60–70%)
whereas control “stop” viruses resulted in only 10–20%
survival in response to camptothecin treatment. Little or
no difference in survival, however, was observed when the
Figure 5. The effects of ex-
pression of DN CDKs on sur-
vival of cultured UV-irradiated
sympathetic neurons. Each
point is the mean 6 SEM of
data from three cultures and
is expressed relative to the
number of neurons present in
each culture at the time of UV
irradiation. Control viruses
for each vector were gener-
ated by removal of the start
codon and in some cases, in-
troduction of a premature stop
site. Effects of overexpression
of (a) Cdk2DN, (b) Cdk3DN,
(c) Cdk4DN, (d) Cdk6DN and
respective controls on the time
course of survival of UV-irra-
diated sympathetic neurons.Park et al. CDKs and Neuronal Death 463
cortical cultures were infected with DN Cdk2 or Cdk3 or
the CAT/Sfcv controls (Fig. 9 b; data not shown).
Cyclin D1–associated Kinase Activity Is Markedly 
Elevated in Camptothecin-treated Cortical Neurons
The observations that DN Cdk4 and 6 protect from neu-
ronal death induced by DNA damage suggest that the ac-
tivities of the corresponding endogenous CDKs should be
elevated in dying neurons. To test this, we measured cyclin
D1–associated kinase activity in extracts of cortical neu-
rons that had been treated for various times with camp-
tothecin. As shown in Fig. 10, we observed a sevenfold in-
crease in cyclin D1–associated kinase activity by 1 h of
treatment. This increase in activity peaked at z10-fold by
2–4 h, and was somewhat diminished at 8 h.
Discussion
Sindbis Viruses as a Gene Delivery System to Evaluate 
Neuronal Death Resulting from DNA-damaging Agents
The Sindbis virus represents a potentially useful and effi-
cient method for targeting heterologous genes to primary
postmitotic neurons. We have previously demonstrated
that the Sindbis virus vector efficiently targets sympathetic
neurons and can be used to evaluate the mechanisms of
death resulting from NGF deprivation. A variety of con-
trol viruses either expressing non-death–related proteins
or with premature stop codons inserted into the heterolo-
gous genes of interest had minimal effect on the kinetics of
death of sympathetic neurons deprived of NGF (Park et
al., 1997b). We now show that such control viruses have
minimal effects on the kinetics of death of sympathetic
neurons exposed to the DNA-damaging agents UV irradi-
ation and AraC. These findings thus indicate that the Sind-
bis virus is also an effective system for evaluating the ef-
fects of exogenous genes in sympathetic neuron death
evoked by DNA damage.
We show here that, as with sympathetic neurons, cul-
tured primary central nervous system (CNS) neurons are
also efficiently targeted by Sindbis viruses. However, un-
like the case of sympathetic neurons, with camptothecin-
treated cortical neurons, there is a small but significant
protective effect of the control viruses themselves. The vi-
ruses also somewhat diminished background survival after
48 h in control cortical cultures. Nevertheless, our analyses
revealed significant differences between responses to con-
trol viruses and to those expressing certain genes related
to cell cycle. Moreover, there was good correspondence
Figure 6. The effects of ex-
pression of DN CDKs on sur-
vival of cultured sympathetic
neurons treated with AraC.
Each data point is the mean
6 SEM of data from three
cultures and is expressed rel-
ative to the number of neu-
rons present in each culture
at the time of AraC treat-
ment. Control viruses for
each vector were generated
by removal of the start codon
and in some cases, introduc-
tion of a premature stop site.
Effects of overexpression of
(a) Cdk2DN, (b) Cdk3DN,
(c) Cdk4DN, (d) Cdk6DN
and respective controls on
the time course of survival
of AraC-treated sympathetic
neurons.The Journal of Cell Biology, Volume 143, 1998 464
between those constructs that were effective in protecting
sympathetic neurons and in protecting cortical neurons.
Accordingly, with appropriate controls, it appears that the
Sindbis virus is a convenient vector for at least short-term
gene targeting to CNS as well as to PNS neurons in cul-
ture.
Cell Cycle and Neuronal Death Resulting from
DNA-damaging Agents
Observations that postmitotic neurons, like proliferating
cells, are vulnerable to DNA topoisomerase-I inhibitors
such as camptothecin, chain terminators such as AraC,
and ionizing radiation led to the suggestion that such
agents evoke neuronal death by causing DNA damage
(Morris and Geller, 1996; Park et al., 1997a). In dividing
cells, these DNA-damaging agents induce and activate
CKIs and the tumor suppressor p53, which acts to regulate
cell cycle progression (Sherr, 1996). This, in turn, raised
the hypothesis that DNA damage may by some means ac-
tivate elements of the cell cycle machinery in neurons that
would participate in activation of an apoptotic pathway
(Park et al., 1997a). This was supported by observations
that non-peptide G1/S blockers and CDK inhibitors sup-
press the death of neuronally differentiated PC12 cells,
sympathetic neurons, and cortical neurons exposed to UV
irradiation, camptothecin, or AraC (Park et al., 1997a). In
light of these findings, we undertook the present experi-
ments to (a) confirm the previous pharmacological evi-
dence implicating CDKs in neuronal death induced by
DNA-damaging agents and (b) identify the particular
CDKs that might be involved.
We report here that death of sympathetic neurons ex-
posed to UV irradiation or AraC can be inhibited by the
CKIs p16, p21, and p27, and that death of cortical neurons
exposed to camptothecin can be inhibited by p16 and p27.
In addition to its CDK inhibitory activity, p21 is reported
to bind to PCNA and to block c-Jun kinase activity, thus
posing alternative means by which it may interfere with
death (Shim et al., 1996). However, p16 does not inhibit
c-Jun kinase (Shim et al., 1996) and this, coupled with the
protective actions of DN Cdk4 and Cdk6, favors a mecha-
nism in which the various CKIs we used suppress death by
virtue of their abilities to interfere with CDK activities.
To extend our experiments with CKIs, we expressed in
neurons various CDKs that contained an Asp to Asn
mutation in the conserved KLADFGLAR kinase consen-
sus domain. Although catalytically inactive, such mutants
should retain their capacity to bind cyclins and hence to
act as DNs. van den Heuval and Harlow (1993) demon-
strated that the mutant forms of Cdk2 and Cdk3 block
progression of actively dividing cells, apparently by acting
as DN antagonists for endogenous CDKs. In the latter
study, the mutated forms of Cdk4 and Cdk6 did not block
proliferation. However, this lack of action may be due to
the finding that Cdk4–cyclin D1 activity may play a more
important role in controlling S phase entry for cells emerg-
ing from quiescence rather than for cells in a state of active
proliferation (Doree and Galas, 1994; Diehl and Sherr,
1997; Connell-Crowley et al., 1998). Although we have not
yet been able to directly test whether the mutated Cdk4
and Cdk6 constructs act as DNs in neurons, recent
cotransfection-based assays in SAOS-2 and MEF7 cells
show that these mutants block the ability of overexpressed
Figure 7. Immunofluorescence staining with an
antibody directed against the FLAG epitope (a,
c) or corresponding light micrographs (b, d) of
cortical neurons in culture infected with Sindbis
virus expressing Cdk3DN-FLAG (c, d) or con-
taining the Cdk3 control sequence (a, b). Neu-
rons were stained 1 d after infection.
Figure 8. Western blot analy-
ses of cortical neurons ex-
pressing FLAG-tagged DN
CDK2/3/4/6 and p27 (a) and
p27 and p16 (b). cont, control
samples in which the neu-
rons were infected with a
control virus. The blots were
analyzed using an anti-FLAG
antibody. Neurons were lysed
after 24-h infection with the
appropriate viruses.Park et al. CDKs and Neuronal Death 465
cyclin D1 to reverse Rb-mediated repression of E2F activ-
ity (S.P. Chellappan, personal communication). The most
likely interpretation of these observations is that the mu-
tant Cdk4 and Cdk6 constructs act as DNs to suppress for-
mation of active complexes between their corresponding
endogenous forms and cyclin D1. Taken together, the
above points strongly support the likelihood that the ki-
nase inactive CDK mutants we used act as DNs.
Our findings revealed that expression of mutated Cdk4
and 6, but not Cdk2 or Cdk3 effectively suppressed death
in our paradigms of DNA damage. In this light, it is signif-
icant that the one set of CDKs that are blocked in com-
mon by the three CKIs we used are Cdk4 and Cdk6 (Sherr
and Roberts, 1995). Our findings that cyclin D1–associ-
ated kinase activity is rapidly elevated in response to DNA
damage of neurons are also consonant with a role for
Cdk4/6 in the pathway by which DNA-damaging agents
cause death of neurons. Finally, our observations are con-
sistent with the reports of the presence of Cdk4 but not
Cdk2 transcripts in sympathetic neurons (Freeman et al.,
1994) and our own findings of the presence of Cdk4 in cor-
tical neurons (Park, D.S., unpublished results). It is also in-
teresting that DN Cdk3 failed to protect neurons from
DNA damage, although Cdk3 has been shown to be re-
quired for cell cycle progression in proliferating cells (van
den Heuvel and Harlow, 1993). It is unknown, however,
whether Cdk3 is present in neurons or whether it is acti-
vated during the death process. Finally, we have previ-
ously shown that the pharmacological CDK inhibitors olo-
moucine and flavopiridol protect sympathetic neurons and
PC12 cells from death resulting from NGF deprivation
and DNA damage (Park et al., 1996a, 1997a). However,
while flavopiridol inhibits Cdk4 activity, olomoucine does
not (Vesely et al., 1994). This suggests that additional
CDKs may also be important for regulation of neuronal
death.
The potential function of Cdk4/6 action in death of sym-
pathetic and cortical neurons treated with DNA-damaging
agents is unclear. One well-studied substrate of Cdk4/6 is
the retinoblastoma protein (pRB). pRB, the product of
the retinoblastoma tumor suppressor gene, appears to play
a role in regulating the G1 phase of the cell cycle (Chellap-
pan et al., 1991; Weinberg, 1995). pRB binds to and inhib-
its the transcription factor E2F and its phosphorylation by
Cdk4/6 suppresses this interaction, thereby permitting
E2F activation. Interestingly, expression of pRB in mul-
tiple cellular contexts, including neurons, is protective
against apoptosis (Berry et al., 1996; Fan et al., 1996; Mac-
leod et al., 1996), while loss of pRB interaction facilitates
death (Liu and Kitsis, 1996; Shan et al., 1996). Also, pRB
Figure 9. Effects of expres-
sion of CDK inhibitors (a) or
DN CDKs (b) on survival of
primary E18 cultured rat cor-
tical neurons treated with
camptothecin (campt). Each
value is the mean 6 SEM of
data from three cultures and
is expressed relative to the
number of neurons present in
each culture at the time of
camptothecin treatment.
Figure 10. Cyclin D1–associated kinase activity is elevated in cor-
tical neurons treated with camptothecin. Cyclin D1–associated
kinase activity was calculated by measuring the incorporation of
P32 onto pRB substrate and subtracting the control background
value. Each point is the mean 6 SEM of data from three separate
experiments. (A) An example autoradiogram showing the incor-
poration of P32 into pRB.The Journal of Cell Biology, Volume 143, 1998 466
knockout mice display excess developmental neuronal cell
death (Jacks et al., 1992; Macleod et al., 1996) and overex-
pression of E2F evokes death in a variety of cell types
(Qin et al., 1994; Hiebert et al., 1995). Accordingly, Cdk4/6
may act in DNA damage–evoked neuronal death to phos-
phorylate pRB thereby altering its functional state and
leading, among other potentially lethal events, to disregu-
lation of E2F activation. In support of this, preliminary ev-
idence suggests that pRB is hyperphosphorylated and de-
graded in camptothecin-treated cortical neurons (Park,
D.S., and E.J. Morris, unpublished results) and a recent re-
port indicates that pRB becomes hyperphosphorylated
during cisplatin-induced death of sensory neurons with
concomitant increase in Cdk4 and cyclin D1 levels (Gill
and Windebank, 1998).
Neuropathies constitute a significant clinical problem in
the therapeutic administration of anticancer agents that
appear to work by damaging DNA. For example, AraC,
which is commonly used in treatment for leukemias, can
cause cerebellar neuropathies (Winkelman and Hines,
1983). In addition, radio- and chemotherapy for brain neo-
plasms results in dose-limiting acute and delayed toxicity
leading to edema, seizures, neuropsychiatric deterioration,
IQ decrements, and death (Levin et al., 1993). Our find-
ings suggest a potential mechanism by which DNA-dam-
aging agents can cause degeneration of postmitotic neu-
rons and specifically point to cell cycle components. Such
knowledge, in turn, may lead to palliative treatments,
perhaps through administration of inhibitors of specific
CDKs.
Comparison between Death Signaling Mediated by 
DNA Damage, Oxidative Stress, and NGF Deprivation
Several lines of evidence have implicated cyclins and
CDKs in apoptosis of neuronal cells caused by withdrawal
of trophic support. For example, NGF deprivation leads to
increased Cdc2 activity and cyclin B expression in neu-
ronal PC12 cells (Brooks, S.F., L.A. Gibson, and L.L. Ru-
bin. 1993. Soc. Neurosci. Abstr. 198:885; Gao and Zalenka,
1995); expression of the CKI p21 is required for survival of
differentiated neuroblastoma cells (Poluha et al., 1996)
and CKI p16 protects neuroblastoma cells from death
caused by trophic factor deprivation (Kranenburg et al.,
1996). In addition, we have previously shown that expres-
sion of CKIs or DN Cdk4/6 protects sympathetic neurons
against NGF deprivation (Park et al., 1997b).
Thus with respect to the involvement of CDKs, our
present experimental findings suggest parallel mechanisms
of cell death evoked by NGF withdrawal and exposure to
DNA-damaging agents. However, our previous evidence
has indicated that the death evoked by these stimuli is not
identical (Park et al., 1998). In particular while death re-
sulting from DNA damage does require induction of
caspase activity, the caspase(s) involved is different than
that mediating death by way of NGF deprivation (which
requires activation of Nedd-2/caspase 2; Troy et al., 1997)
or to oxidative stress induced by superoxide dismutase 1
depletion (which requires ICE or ICE-like activity; Troy
et al., 1996). Moreover, death caused by oxidative stress is
not prevented by CDK inhibitors nor is that triggered by
oxidative stress or DNA-damaging agents blocked by the
presence of NGF (Park et al., 1998). Consequently, it can
be anticipated that in addition to CDKs, additional path-
way-specific elements must distinguish the mechanism by
which DNA-damaging agents trigger neuronal apoptosis.
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